The company, which emerged from Paragon Therapeutics, is developing bowel disease drugs similar to Takeda’s Entyvio and an experimental Prometheus drug just bought by Merck & Co.A new biotechnology company with plans to develop better bowel disease drugs emerged Thursday with hundreds of millions of dollars in funding and a deal that places it on […]

Author